|1.||Vestibular Neuronitis (Vestibular Neuritis)
|2.||Vertigo (Positional Vertigo)
|4.||Sensorineural Hearing Loss
|5.||Conductive Hearing Loss
|1.||Koval, J: 1 article (01/2012)|
|2.||Krempaska, S: 1 article (01/2012)|
|3.||Draper, T H J: 1 article (04/2009)|
|4.||Bamiou, D-E: 1 article (04/2009)|
|2.||T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/01/1998 - "The development of T cell receptor-specific antibody therapy might help treat retrocochlear hearing loss in multiple sclerosis."
11/01/1998 - "We demonstrated that mice with experimental allergic encephalomyelitis developed retrocochlear hearing loss, and that the lesion of the auditory pathway might be related to T cell receptor Vbeta8-expressing T cells. "
11/01/1998 - "Successful prevention of retrocochlear hearing loss in murine experimental allergic encephalomyelitis with T cell receptor Vbeta8-specific antibody."
|3.||Benign paroxysmal positional vertigoIBA
01/01/2012 - "WE have examined 218 patients with cochleovestibular symptomatology (sudden sensorineural cochlear hearing loss, retrocochlear hearing loss, vestibular neuronitis, benign paroxysmal positional vertigo (BPPV), Meniere´s disease, central vestibular disorder, as well as vertigo of non vestibular ethiology and 32 patients with conductive hearing loss with VEMP testing. "